Bivalent vaccine registers only 0.02 percent of possible adverse effects, according to ISP study
A study carried out by the Institute of Public Health (ISP) concluded that the bivalent vaccine, which contains a combination of the original variant of Covid-19 and Ómicron, only registers a 0.02 percent possible adverse effects. In Chile, immunization with this vaccine from the Pfizer and Moderna laboratories began last October and to date 1.9 … Read more